Glenmark Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Glenmark Pharma	Abbott India	Alkem Laboratories
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	13.0 .	n/a	187.0 .
Number of ANDA's Approved By USFDA	25.0 .	n/a	163.0 .
Domestic Sales Growth - YoY	10.3 %	8.2 %	73.0 %
R&D as a % of Total Sales	7.3 %	0.02 %	3.3 %
Financials
5 yr Average ROE	3.99 %	30.11 %	17.38 %
5yr average Equity Multiplier	1.78	1.43	1.39
5yr Average Asset Turnover Ratio	0.8	1.14	0.86
5yr Avg Net Profit Margin	2.85 %	18.53 %	14.54 %
Price to Book	5.98	15.1	4.86
P/E	56.72	40.15	27.45
5yr Avg Cash Conversion Cycle	-150.94 Days	-46.68 Days	-61.46 Days
Inventory Days	32.28 Days	45.22 Days	56.11 Days
Days Receivable	32.34 Days	19.34 Days	44.62 Days
Days Payable	201.14 Days	109.21 Days	122.42 Days
5yr Average Interest Coverage Ratio	4.25	97.37	24.48
5yr Avg ROCE	17.54 %	38.77 %	22.76 %
5yr Avg Operating Profit Margin	15.96 %	23.42 %	18.44 %
5 yr average Debt to Equity	0.38	0.0	0.18
5yr CAGR Net Profit	1.54 %	95.4 %	6.44 %
5yr Average Return on Assets	2.09 %	21.03 %	12.47 %
Shareholdings
Promoter Holding	46.65 %	74.99 %	51.2 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	-5.96 %
Change in Mutual Fund Holding (3 Yrs)	10.05 %	2.11 %	7.52 %

Business

	Glenmark Pharma	Abbott India	Alkem Laboratories
Product Wise Break-Up	Product Wise Break-Up Branded Generics 60.46 Formulations 39.54 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Hormones 0 Anti Diabetic 0 Central Nervous System 0 Respiratory 0 Vaccines 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Women`s health 0 Gastro Intestinal 0 Pain 0 Pharmaceutical 0	Product Wise Break-Up Respiratory 0 Derma 0 Pharmaceutical 0 Metabolic 0 Pain 0 Vaccines 0 Hepatoprotectives 0 Branded Generics 0 Anti-Infectives 0 Anti Diabetic 42.82 cardiovascular system 0 Formulations 0 Women`s health 0 Vitamin, Minerals & Nutrition 0 Central Nervous System (CNS) 12.65 Hormones 11.59 Gastro Intestinal 25.46 Others 7.48	Product Wise Break-Up Respiratory 0 Derma 0 Pharmaceutical 100.0 Metabolic 0 Pain 0 Vaccines 0 Hepatoprotectives 0 Branded Generics 0 Anti-Infectives 0 Anti Diabetic 0 cardiovascular system 0 Formulations 0 Women`s health 0 Vitamin, Minerals & Nutrition 0 Central Nervous System 0 Hormones 0 Gastro Intestinal 0
Location Wise Break-Up	Location Wise Break-Up North America 73.99 Europe 12.36 Rest of the World 10.91 India 2.73 Latin America 0 USA 0 Others 0.01	Location Wise Break-Up India 98.81 Latin America 0 Rest of the World 1.19 North America 0 USA 0 Europe 0	Location Wise Break-Up India 69.13 Latin America 0 Rest of the World 0 North America 0 USA 29.72 Europe 0 Others 1.15
Asset Break-Up	Asset Break-Up India 49.4 North America 42.56 Rest of the World 4.94 Europe 3.09 Latin America 0 USA 0 Others 0.01	-	Asset Break-Up India 70.19 Latin America 0 Rest of the World 0 North America 0 USA 28.27 Europe 0 Others 1.54

Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE